Cancer Research Brief: Targeting Pancreatic Cancer Drug Resistance

Published July 11, 2013

Cancer research brief: Targeting pancreatic cancer drug resistance

Filed under: christian drug rehab

The molecule FG-3019, a fully-human proprietary monoclonal antibody developed by Fibrogen, Inc. that is now in phase 1/2 clinical investigation as a treatment option for pancreatic cancer, binds to CTGF and prevents it from providing cells with …
Read more on HealthCanal.com

Xanax Addiction Treatment and Xanax Drug Rehab Announced by Recovery …

Filed under: christian drug rehab

Their unique program offers three different tracks: a Traditional Drug Rehab Track, an Expressive Therapies Track, Teen Rehab Track, and a Christian Rehab Track. They believe that by utilizing a variety of therapies they can better assist their clients …
Read more on PR Web (press release)

Clashes by Egypt army, protesters kill at least 54

Filed under: christian drug rehab

A wounded supporter of Egypt's ousted President Mohammed Morsi receives treatment at a local hospital in Cairo, Egypt, Monday, July 8, 2013. Egyptian soldiers and police guarding the Republican Guard building opened fire on supporters of the ousted …
Read more on Ellwood City Ledger